@SignantHealth profile picture
Signant Health @SignantHealth

Signant is the evidence generation company. Our SmartSignals suite combines software with deep scientific expertise to deliver high quality #clinicaltrial data

Joined May 2019
  • Tweets 1,235
  • Following 643
  • Followers 656
1,114 Photos and videos
Pinned Tweet
Signant Health @SignantHealth
21 Jan 2025
Attend our #SCOPE2025 session "Practical Innovations with AI and Automation" to hear how we're transforming clinical research via AI-powered solutions. Schedule a meeting at booth #1013 to discover how cutting-edge approaches accelerate trial success. hubs.li/Q033lRXM0
0:39
267
Subjective rating scales may challenge #immunology trials. The fix: electronic assessments with built-in standardization, specialized rater training, and real-time analytics. See this in a PsA trial: hubs.li/Q03xFQzr0 #ClinicalTrials
104
At AAIC2025, our clinical science team will present data on screening optimization and endpoint reliability—two critical factors in successful Alzheimer’s disease trial design. Schedule time with our experts or get pre-conference resources: hubs.li/Q03xs13q0
0:17
85
Complex designs such as adaptive basket or umbrella trials are making RTSM builds more challenging. This blog covers best practices for implementation of adaptive trials: hubs.li/Q03wDz9n0 #RTSM #ClinicalTrials #AdaptiveTrials
60
Supply shortages derail study timelines and inflate budgets. Our Forecasting & Planning solution enables effective planning to prevent stockouts with real-time usage data and predictive modeling across your entire supply chain.  Protect study timelines: hubs.li/Q03vMzHq0
0:17
1
1
74
Alzheimer’s trials are a maze. Let’s untangle the complexity together. Visit booth 1334 to talk with our team about optimal study design, reducing rater variability, ensuring eligibility, & building more signal-rich dementia trials. See details posters: hubs.li/Q03vCXg30
34
Signant's ops team has been recognized as a finalist for the OnCon Icon Top 100 Operations Team award. This recognition underscores our commitment to operational excellence as a catalyst for clinical research. Support innovation by voting for us: hubs.li/Q03vtr6S0
43
When choosing an eClinical partner, biotechs and emerging biopharma shouldn’t have to choose between working with an established, full-service company and a provider with a hands-on approach. Get the best of both worlds: hubs.li/Q03tQxvT0
39
How can PRO data help inform optimal dose selection in early-phase #oncology #clinicaltrials? Our new guide makes the case for incorporating patient experience data for a more complete tolerability assessment. Get it here: hubs.li/Q03tyk9c0
0:21
39
Running GLP-1 RA trials? Our ePRO handles the complexities – from dose escalation tracking and cardiovascular assessments to participant retention. Streamline your data capture and engagement strategy: hubs.li/Q03tmgyq0
0:33
1
62
Our new "Getting Started with eCOA" series is your go-to resource for mastering the essentials of electronic COAs. Explore our quick-read guides and get the insights you need to succeed. Check it out now: hubs.li/Q03sHcfP0 #ClinicalTrials #eCOA #PatientCentricity
0:20
32
The therapeutic promise of #psychedelic compounds is real, but so are the scientific challenges. Our latest blog reveals evidence-based strategies to maintain methodological rigor and study integrity in psychedelic #clinicaltrials: hubs.li/Q03sfmDD0
1
29
Early detection of cognitive effects can make or break your clinical program. Our CDR system's attention battery identifies cognitive changes in early-phase #clinicaltrials, helping you make confident decisions before costly failures hubs.li/Q03rT4T40
1:15
36
🚀 Our TrialMax® platform features automation for the Data Change Form (DCF) process, reducing manual efforts, minimizing errors, and speeding up data management. Learn how TrialMax® is revolutionizing #eCOA study delivery: hubs.li/Q03rHZXD0
23
How might placebo response and expectation bias impact #clinicaltrial outcomes? How can they be mitigated to ensure data reliability? Get answers from experts here: hubs.li/Q03rrgfB0
23
Pediatric depression #clinicaltrials have challenges: limited sites, variable CDRS-R administration, and complex multi-stakeholder interviews. See how our CDRS-R solution addresses them: hubs.li/Q03qS4BM0 #pediatricdepression
21
Accelerate your vaccine research with trial-tested eCOA, RTSM, eConsent, telemedicine, and patient Engagement solutions. With experience in 200 studies across 30 countries, we're ready to help bring your vaccine to the public quickly and efficiently. hubs.li/Q03qFDSp0
25
Leading technology without limits: Global pharmaceutical leaders rely on our comprehensive #eCOA, eClinRO, and #RTSM solutions for reliable evidence generation. No surprises, just flexible tech backed by expert teams. Explore industry-standard solutions: hubs.li/Q03qqH4H0
0:20
35
Sites using too many systems? Our EDC offers add-on modules for eCOA, eConsent, and Randomization. One platform, one login, and happy sites. Take a look: hubs.li/Q03p_C9P0
24
The placebo effect is a contributing factor in the low success rates of novel pain medication #clinicaltrials, where less than 5% of low-abuse potential drugs gain approval. See how we helped one pharma company limit placebo effect and gain FDA approval: hubs.li/Q03pXfwG0
23
With our novel patient-reported outcome measure, PROMIS CAT, study teams can capture precise data from fewer questions or items, reducing completion burden for patients. Bonus: Incorporate it alongside traditional COAs. Get details: hubs.li/Q03pHd0z0
21
Load more